Trial drug shown to significantly slow early Alzheimer’s decline
A Phase 3 clinical trial of the drug donanemab has shown it can significantly slow cognitive and functional decline in people with early-stage Alzheimer’s disease, compared with existing treatments.
Category: Health & Wellbeing, Lifestyle
Tags: Alzheimer’s Disease, Dementia, Immunotherapy, Drug, Neural Network, antibodies
Continue reading Trial drug shown to significantly slow early Alzheimer’s decline